D-0007-2026 Class II Ongoing
FDA drug recall D-0007-2026 was initiated by AvKARE on Sep 2, 2025 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications The recall status is ongoing. Affected quantity: 2192 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 15, 2025
- Initiation Date
- Sep 2, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2192 cartons
Product description
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Reason for recall
Failed Content Uniformity Specifications
Distribution pattern
U.S. Nationwide
Code information
Lot # LF41138A; Exp 06/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0007-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026